Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Sookmyung Women'S University Industry-Academic Cooperation Foundation has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 4 distinct examiners and 4 distinct art units, indicating separate examiner and technical-unit settings for the pending work.
LI, TRACY Y is the busiest examiner, with 1 pending matter. No examiner has a larger identified workload, so counsel should prioritize coordinated docket tracking and tailored responses across the separate prosecution paths.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALAM, AYAAN A | 1 | 38.8% | +36.4% |
| ROZOF, TIMOTHY R | 1 | 72.7% | +23.3% |
| TRINH, THANH TRUC | 1 | 22.1% | +10.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18951216 | Composition for Neuroprotection, Containing Plant Extract or Fraction as Active Ingredient | ALAM, AYAAN A | — |
| 18847251 | NOVEL HETEROCYCLIC INHIBITOR FOR HISTONE DEACETYLASE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | ROZOF, TIMOTHY R | — |
| 18708088 | ELECTRODE OF DYE-SENSITIZED SOLAR CELL AND METHOD FOR MANUFACTURING THE SAME | TRINH, THANH TRUC | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18951216 | Composition for Neuroprotection, Containing Plant Extract or Fraction as Active Ingredient | ALAM, AYAAN A | — |
| 18847251 | NOVEL HETEROCYCLIC INHIBITOR FOR HISTONE DEACETYLASE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | ROZOF, TIMOTHY R | — |
| 18708088 | ELECTRODE OF DYE-SENSITIZED SOLAR CELL AND METHOD FOR MANUFACTURING THE SAME | TRINH, THANH TRUC | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| 1625 | 1 |
| 1726 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18951216 | Composition for Neuroprotection, Containing Plant Extract or Fraction as Active Ingredient | ALAM, AYAAN A | 1611 | §101§102§112 | Non-Final OA | — | Pending | Nov 18, 2024 |
| 18847251 | NOVEL HETEROCYCLIC INHIBITOR FOR HISTONE DEACETYLASE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | ROZOF, TIMOTHY R | 1625 | §102§112 | Non-Final OA | — | Pending | Sep 15, 2024 |
| 18708088 | ELECTRODE OF DYE-SENSITIZED SOLAR CELL AND METHOD FOR MANUFACTURING THE SAME | TRINH, THANH TRUC | 1726 | §103 | Non-Final OA | — | Pending | May 07, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSookmyung Women'S University Industry-Academic Cooperation Foundation has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Ayaan A Alam has the most, with 1 of Sookmyung Women'S University Industry-Academic Cooperation Foundation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
